Synairgen (SNG)

 

SNG Share PerformanceMore

52 week high36.00 04/10/16
52 week low6.98 05/09/17
52 week change -24.25 (-69.29%)
4 week volume9,612,918 24/08/17

Media for (SNG)

Presenter: Richard Marsden, CEO
11/11/2014
Presenter: Richard Marsden
08/07/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

Notification of major interests in shares

Synairgen's PXS-5382A to be prepared for Phase I clinical development

Synairgen announced following the successful completion of preclinical pharmacology and toxicology studies, a compound...

LOXL2 Inhibitor Update.

Miscellaneous medium priority announcements

Synairgen shareholders pass all resolutions at AGM

Synairgen has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:01pm: (LO...

Result of AGM

Notification of the result of any voting at an AGM

Posting of Annual Report and Notice of AGM

Miscellaneous medium priority announcements

Preliminary Results

Announcement of full year/4th quarter financial results

US tax reform plans and ex-dividends push FTSE lower

Investors were disappointed with a lack of detail on US President Donald Trump's tax reform plans, while stocks going ex-d...

Fundamental DataMore

EPS-3.08
Dividend yield0 %

Equity Research (SNG)

edison investment research
Synairgen
14/07/2014
The recent exclusive global deal with AstraZeneca, potentially worth $230m, to in-license SNG001 for the treatment of asthma is a strong validation of Synairgen’s in-vitro cell-based approach using...

Latest discussion posts More

  • Pharmaxis on LOXL

    Synairgen partnering Pharmaxis 50/50 as the drug goes into phase 1 trials https://www.youtube.com/watch?v=6uIXJ22ESb4 SNG still hugely undervalued ,....
    8-Sep-2017
    mr1christian
  • Shame.

    Synairgen plc ('Synairgen' or the 'Company') AZD9412 Update ? Cold infections did not affect trial patients' asthma in the INEXAS study as much as predicted, ...
    27-Apr-2017
    Disorder
  • Re: :-)

    Yes very encouraging. Also waiting for the akzo decision or not? Thanks for the tippage. Up a great deal again!
    10-Mar-2017
    high blood pressure1

Users' HoldingsMore

Users who hold Synairgen also hold..
PREMIER OIL29%
ID:ISIN:VGG9828A119419%
JUBILEE PLAT.19%
RENEURON16%
RANGE RES.16%

Codes & Symbols

ISINGB00B0381Z20
SymbolsSNG, LSE:SNG, SNG.L, SNG:LN, LON:SNG, XLON:SNG